Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection

Hepatology Research

Volumn 34, Issue 4, 2006, Pages 214-221

  Ayada, Minoru ^a   Ishikawa, Tetsuya ^a   Okumura, Akihiko ^a   Tanabe, Junichi ^a,b   Ito, Hiroyasu ^a   Ohashi, Tomohiko ^a   Matsumoto, Eiji ^a   Sato, Ken ^a   Hotta, Naoki ^a   Fukuzawa, Yoshitaka ^a   Kakumu, Sinichi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

HBV; IL 10; IL 12 p40; IL 12 p70; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

EID: 33645027908     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.01.001     Document Type: Article

References (30)

1. F.V. Chisari C. Ferrari Hepatitis B virus immunopathogesis Ann Rev Immunol 13 1995 29-60
2. B. Rehermann D. Lau J.H. Hoofnagle F.V. Chisari Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection J Clin Invest 97 1996 1655-1665
3. A. Penna G. Del Prete A. Cavalli et. al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B Hepatology 25 1997 1022-1027
4. A. Bertoletti M.M. D'Elios C. Boni et. al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections Gastroenterology 112 1997 193-199
5. K. Ando T. Moriyama L.G. Guidotti et. al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis J Exp Med 178 1993 1541-1554
6. L.G. Guidotti K. Ando M.V. Hobbs et. al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mouse Proc Natl Acad Sci USA 91 1994 3764-3768
7. L.V. Tsui L.G. Guidotti T. Ishikawa F.V. Chisari Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes Proc Natl Acad Sci USA 92 1995 12398-12402
8. L.G. Guidotti T. Ishikawa M.V. Hobbs B. Matzke R. Schreiber F.V. Chisari Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 4 1996 25-36
9. L.G. Guidotti R. Rochford J. Chung M. Shapiro R. Purcell F.V. Chisari Viral Clearance without destruction of infected cells during acute HBV infection Science 284 1999 825-829
10. R.G. Wells The roles of matrix stiffness in hepatic stellate cell activation and liver fibrosis J Clin Gastroenterol 39 2005 S158-S161
11. R. Bataller D.A. Brenner Liver fibrosis J Clin Invest 115 2005 1100
12. H. Hirofuji S. Kakumu A. Fuji et. al. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells Clin Exp Immunol 68 1987 348-356
13. Y. Shirai S. Kawata S. Tamura et. al. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases Cancer 73 1994 2275-2279
14. W. Rossmanith R. Schulte-Hermann Biology of transforming growth factor beta in hepatocarcinogenesis Microsc Res Tech 52 2001 430-436
15. K. Okumoto E. Hattori K. Tamura et. al. Possible contribution of circulating transforming growth factor-beta 1 to immunity and prognosis in unresectable hepatocellular carcinoma Liver Int 24 2004 21-28
16. W.C. Lee Y.J. Chiang H.C. Wang et. al. Functional impairment of dendritic cells caused by murine hepatocellular carcinoma J Clin Immunol 24 2004 145-154
17. A. D'Andrea M. Rengaraju N.M. Valiante et. al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells J Exp Med 176 1992 1387-1398
18. J. Ludwig The nomenclature of chronic active hepatitis: An obituary Gastroenterology 105 1993 274-278
19. Ichida F, Tsuji T, Omata M, et al. New criteria for histological diagnosis of chronic hepatitis. Archives of 18th Inuyama Symposium. Japan: Chugai-igaku Inc.; 1994. p. 38-41.
20. L.H. Song V.Q. Binh N. Dinh et. al. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus J Clin Virol 2003 93-103
21. N. Hyodo M. Tajimi T. Ugajin I. Nakamura M. Imawari Frequencies of interferon-γ and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection Hepatol Res 27 2003 109-116
22. H. Bozkaya M. Bozdayi R. Turkyilmaz et. al. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: Their relations to HBeAg status and the activity of liver disease Hepatogastroenterol 47 2000 1675-1679
23. N. Hyodo I. Nakamura M. Imawari Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection Clin Exp Immunol 135 2004 462-466
24. R.P. Beasley Hepatitis B virus. The major etiology of hepatocellular carcinoma Cancer 61 1988 1942-1956
25. M.C. Yu J. Yuan R.K. Ross S. Govindarajan Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California Hepatology 25 1997 226-228
26. M.H. Chang C.J. Chen M.S. Lai et. al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular cancinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1997 1855-1859
27. T.M. Hagen S. Huang J. Curnutte et. al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destinated to develop hepatocellular carcinoma Proc Natl Acad Sci USA 91 1994 12808-12812
28. K.B. Schwarz M. Kew A. Klein et. al. Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma Dig Dis Sci 46 2001 2173-2178
29. N.M. Wheelhouse Y.S. Chan S.E. Gillies et. al. TNF-alpha induced DNA damage in primary murine hepatocytes Int J Mol Med 12 2003 889-894
30. M. Ichiba Y. Maeta T. Mukoyama et. al. Expression of 8-hydroxy-2′-deoxyguanosine in chronic liver disease and hepatocellular carcinoma Liver Int 23 2003 338-345